Avecho Biotechnology Ltd banner

Avecho Biotechnology Ltd
ASX:AVE

Watchlist Manager
Avecho Biotechnology Ltd Logo
Avecho Biotechnology Ltd
ASX:AVE
Watchlist
Price: 0.009 AUD -5.26% Market Closed
Market Cap: AU$33.1m

Avecho Biotechnology Ltd
Investor Relations

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, and Veterinary Applications. The firm's segments include Production and Personal Care and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches. The Human Health segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Paul Gavin BSc (Hons), Ph.D.
Chief Executive Officer
No Bio Available
Dr. Roksan Libinaki Ph.D.
Chief Operating Officer
No Bio Available
Ms. Melanie Jaye Leydin B.Bus, C.A.
Company Secretary & CFO
No Bio Available

Contacts

Address
VICTORIA
Melbourne
Unit A8, 2A Westall Road, Clayton
Contacts
+61390025000.0
avecho.com.au
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett